Work

Molecularly Targeted Combination Therapy for Advanced Phase Myeloproliferative Neoplasm: MPN-RC 119

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-164678

Authors: Michal Bar-Natan, John Mascarenhas, Aaron T. Gerds, Ruben Mesa, Vikas Gupta, Marina Kremyanskaya, Mikaela Dougherty, Frank Fabris, Kathryn Johnson, Ashley Yu, Heidi E. Kosiorek, Carolyn Mead-Harvey, Amylou C. Dueck, Ronald Hoffman, Raajit K Rampal

Institutions: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Cleveland Clinic, The University of Texas at San Antonio Health Science Center, Mays Cancer Center at UT Health San Antonio, University Health Network, Mayo Clinic, Mayo Clinic in Arizona, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310089983

FWCI: 1.394

Cites:

Cited by: 11

Related to: 10